Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review-Reference-Cited by-同舟云学术

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review

Published:2018-05-21 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Yokoyama Takanori,Takehara Kazuhiro,Sugimoto Nao,Kaneko Keika,Fujimoto Etsuko,Okazawa-Sakai Mika,Okame Shinichi,Shiroyama Yuko,Yokoyama Takashi,Teramoto Norihiro,Ohsumi Shozo,Saito Shinya,Imai Kazuho,Sugano Kokichi

Funder

The National Cancer Center Research and Development Fund

Practical Research for Innovative Cancer Control

Program for Promoting Practical Applications of Genomic Medicine from the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4489-0.pdf

Reference15 articles.

1. Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, et al. EPICOLON Consortium. Identification of lynch syndrome among patients with colorectal cancer. JAMA 2012 ;308:1555–1565.

2. Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. French Cancer genetics network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in lynch syndrome. JAMA. 2011;305:2304–10.

3. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology. 1999;116:1453–6.

4. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–8.

5. Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, et al. Genetic/familial high-risk assessment: colorectal version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:1010–30.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes;Heliyon;2024-08

2. A comparative analysis of MMR immunohistochemistry panels: Evaluating the utility of four-protein versus two-protein panels in endometrial cancer patients;Journal of the Formosan Medical Association;2024-08

3. Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers;Diagnostics;2024-04-24

4. MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome;The Journal of Molecular Diagnostics;2024-02

5. Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signatures;2024-01-21